Jaekuen Lee

Supply Chain Planner with 6+ years of end-to-end demand & supply planning experience in the healthcare, medical device, and pharmaceutical industries, most recently managing a USD 153M multi-BU portfolio across four APAC markets (Korea, China, Taiwan, Hong Kong) at Baxter Korea. Proven leader of monthly IBP/S&OP cycles, integrating top-down financial targets with bottom-up market intelligence — hospital tenders, promotional calendars, competitor stock-out signals — to drive forecast accuracy and consensus across Sales, Marketing, Finance, and Regulatory Affairs. Demonstrated ability to balance seemingly competing priorities by simultaneously securing a 30% increase in strategic stock coverage (77WD → 99WD) and delivering a 20% inventory reduction versus budget (~USD 8M), while maintaining annual discard provisions at approximately 0.06% of total portfolio value through a rigorous SLOB early-warning system.

Specialist in complex regulatory transitions — spinoffs, site transfers, NPLs, MDR/GMP/MAH changes — with a track record of on time product availability across 10+ lifecycle events in a highly regulated MFDS environment. Proficient in SAP, JDE, Rapid Response, Blue Yonder, and Power BI/Tableau, combining systems fluency with strong cross-functional and global stakeholder collaboration.

SCM Supply Planner at Baxter Korea (2023-02 – 2026-08)

Led end-to-end demand & supply planning for a USD 153M multi-BU portfolio — spanning Advanced Surgery(KR), Pharmaceutical (KR/CN/TW/HK)with Local Capex— operating a 24-month rolling forecast across five Business Units and serving as the primary intercompany contact for global manufacturing sites in the US, Puerto Rico, Germany, Belgium and China.

• Led end-to-end demand & supply planning for a USD 153M multi-BU portfolio across 4 APAC markets (KR/CN/TW/HK) and 5 Business Units, operating a 24-month rolling forecast.
• Led monthly IBP/S&OP review meetings, challenging assumptions and figures to solicit functional knowledge and improve forecast accuracy across Sales, Marketing, RA, and Global Planning.
• Submitted periodic Net Requirement Forecasts through SAP/Rapid Response based on cross-functional discussion, sales forecasts, new product launches, and phase-in/out schedules.
• Conducted demand probability analysis to flag supply risk 3–12 months ahead of commercial impact, providing proactive S&OP heads-up for target recalibration before quarter close.
• Reviewed and managed system-generated STOs, placed manual STOs when required, and maintained SNP planning parameters, minimizing manual intervention.
• Acted as primary intercompany contact for global manufacturing sites (US, Puerto Rico, Germany, Belgium, China), following up and expediting shipments.
• Integrated approx. 55 working days of total Quality release lead time (including MFDS National Lot Release) into safety stock and import scheduling for biologics (Floseal, Tisseel).
• Managed short UBD, inactive inventory, and phase-in/phase-out items, reconciling ERP inventory against WH/3PL/field inventory and coordinating periodic inventory counts.
• Monitored and drove reduction of DOH, and coordinated inventory allocation/transfer during supply constraint or excess situations, including cross-country stock swap evaluation.
• Coordinated cross-functional (RA/SC/Commercial) alignment for 10+ complex regulatory lifecycle events — spinoffs, site transfers, NPLs, GMP/MAH changes — with proactive stockpile strategy from 12 months out to Day 1.
• Managed import/export and customs clearance processes, working with Regulatory Affairs to ensure valid import licenses.
• Secured +30% Strategic Stock (77WD → 99WD) by challenging a global inventory reduction mandate with local market data (tenders, promotions, demand volatility), reframing it as a 'supply reliability' KPI rather than 'buffer stock.'
• Achieved a 20% inventory reduction vs. year-end budget (approx. USD 8M, CN Pharma) through lifecycle management and safety stock recalibration.
• Maintained annual discard provisions under USD 100K (~0.06% of total portfolio value) via a rigorous early-warning system for short-expiry and SLOB inventory.
• Maintained on time product availability across 10+ complex regulatory transitions (Spinoffs/ MAH change, site transfers, NPLs, GMP/Label changes).
• Managed multiple concurrent live supply escalations: [Tisseel] post-stockout demand surge (global allocation request, inter-country swap evaluation); [Adept] MDR timeline compression (sales risk assessment, global escalation); [Caelyx] site transfer OOS risk (weekly mitigation calls); [Oncology] FDA audit-driven yield drop (daily monitoring, priority allocation).

SCM Planning Operations at Smith & Nephew Korea (2022-08 – 2023-02)

Executed supply and demand planning for the Sports Medicine & ENT portfolios, serving as the primary APAC supply status contact during a period of significant global supply chain disruption.

• Executed supply and demand planning for Sports Medicine & ENT portfolios, conducting supply/demand/inventory simulations to maintain optimal safety stock under global supply disruption.
• Served as primary APAC supply status call contact, synchronizing local Korean demand signals with regional production plans across manufacturing sites.
• Reviewed weekly inventory reorder and ad-hoc reports, placing purchase/transfer orders with appropriate suppliers to keep inventory within target levels.
• Managed import customs clearance and coordinated with external vendors on product storage and local delivery shipments.
• Maintained SAP master data integrity to enable accurate system-generated supply plans and monitored backorders in coordination with Customer Service.
• Maintained high service levels (OTIF) and minimized backorders for Sports Medicine & ENT despite severe global supply chain disruption.
• Ensured zero supply gap across multiple concurrent NPL and RA permit-change transitions.

SCM Consignment Operations at Alcon Korea (2021-09 – 2022-08)

Managed consignment and contractual inventory across multiple hospitals and clinic accounts for a surgical and vision-care portfolio, acting as the primary contact for all inventory-related enquiries.

• Monitored consignment inventory and contractual stock management across multiple hospital/clinic accounts, acting as primary contact for inventory enquiries.
• Investigated excessive inventory and service-level failure situations, tracking DOS and Working Capital KPIs and ensuring corrective actions to prevent recurrence.
• Operated an early-warning obsolete-stock (E&O) program, coordinating with Sales and Marketing on liquidation/phase-out actions before write-off materialized.
• Reconciled inventory discrepancies in ERP (JDE) against WH/3PL/field inventory, coordinating periodic counts for 99%

B.A. in Public Administration – Sang Myung University (2012 – 2019)